RxDoctor Payments Data

Charles Parkman

Pulmonary Disease · Hattiesburg, MSNPI 1558479998

Payments from drug & device makers

$2,724in general payments, 2019–2025

Across 165 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$788
  • AstraZeneca$246
  • Grifols USA, LLC$227
  • Sanofi$224
  • Genentech USA, Inc.$181
  • Sunovion Pharmaceuticals Inc.$174
  • plus $883 from 15 others

What the payments were for

  • Food & beverage$2,724100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,724 in reported general payments places this provider in the 35th percentile of 101 pulmonary disease providers in Mississippi.

See all pulmonary disease providers in Mississippi

Other pulmonary disease in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →